Alessandra Pavesio - 10 Feb 2022 Form 4 Insider Report for Bioventus Inc. (BVS)

Role: SVP & CHIEF SCIENCE OFFICER
Signature: /s/ Anthony D'Adamio, Attorney-in-Fact
Issuer symbol: BVS
Transactions as of: 10 Feb 2022
Net transactions value: +$952,025
Form type: 4
Filing time: 14 Feb 2022, 19:43:04 UTC
Next filing: 15 Feb 2022
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	BVS	Class A Common Stock	Options Exercise		+191,708	+19171%		192,708	10 Feb 2022	Direct	F1
transaction	BVS	Class A Common Stock	Tax liability	$952,025	+73,915	+165%	$12.88	118,793	10 Feb 2022	Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	BVS	Phantom Profit Units	Options Exercise	$0	-191,708	-100%	$0.000000^*	0	10 Feb 2022	Class A Common Stock	191,708		Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Each Phantom Profit Unit represented a contingent right to receive one share of Class A common stock and vested on the one-year anniversary of the consummation of the Isuser's initial public offering.